Literature DB >> 21795345

Major histocompatibility complex-dependent cytotoxic T lymphocyte repertoire and functional avidity contribute to strain-specific disease susceptibility after murine respiratory syncytial virus infection.

Birthe Jessen1, Simone Faller, Christine D Krempl, Stephan Ehl.   

Abstract

Susceptibility to respiratory syncytial virus (RSV) infection in mice is genetically determined. While RSV causes little pathology in C57BL/6 mice, pulmonary inflammation and weight loss occur in BALB/c mice. Using major histocompatibility complex (MHC)-congenic mice, we observed that the H-2(d) allele can partially transfer disease susceptibility to C57BL/6 mice. This was not explained by altered viral elimination or differences in the magnitude of the overall virus-specific cytotoxic T lymphocyte (CTL) response. However, H-2(d) mice showed a more focused response, with 70% of virus-specific CTL representing Vβ8.2(+) CTL directed against the immunodominant epitope M2-1 82, while in H-2(b) mice only 20% of antiviral CTL were Vβ9(+) CTL specific for the immunodominant epitope M187. The immunodominant H-2(d)-restricted CTL lysed target cells less efficiently than the immunodominant H-2(b) CTL, probably contributing to prolonged CTL stimulation and cytokine-mediated immunopathology. Accordingly, reduction of dominance of the M2-1 82-specific CTL population by introduction of an M187 response in the F1 generation of a C57BL/6N × C57BL/6-H-2(d) mating (C57BL/6-H-2(dxb) mice) attenuated disease. Moreover, disease in H-2(d) mice was less pronounced after infection with an RSV mutant failing to activate M2-1 82-specific CTL or after depletion of Vβ8.2(+) cells. These data illustrate how the MHC-determined diversity and functional avidity of CTL responses contribute to disease susceptibility after viral infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795345      PMCID: PMC3196413          DOI: 10.1128/JVI.00816-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

Review 1.  Respiratory syncytial virus: old challenges and new approaches.

Authors:  Susana Chávez-Bueno; Asunción Mejías; Hasan S Jafri; Octavio Ramilo
Journal:  Pediatr Ann       Date:  2005-01       Impact factor: 1.132

2.  Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections.

Authors:  Simone Vallbracht; Heike Unsöld; Stephan Ehl
Journal:  Eur J Immunol       Date:  2006-06       Impact factor: 5.532

3.  Role of virus and host variables in virus persistence or immunopathological disease caused by a non-cytolytic virus.

Authors:  D Moskophidis; M Battegay; M van den Broek; E Laine; U Hoffmann-Rohrer; R M Zinkernagel
Journal:  J Gen Virol       Date:  1995-02       Impact factor: 3.891

4.  Characterization of the CD8+ T cell responses directed against respiratory syncytial virus during primary and secondary infection in C57BL/6 mice.

Authors:  Michaël V Lukens; Erwin A W Claassen; Patricia M A de Graaff; Mariska E A van Dijk; Peter Hoogerhout; Mireille Toebes; Ton N Schumacher; Robbert G van der Most; Jan L L Kimpen; Grada M van Bleek
Journal:  Virology       Date:  2006-05-30       Impact factor: 3.616

Review 5.  Respiratory syncytial virus: A continuing culprit and conundrum.

Authors:  C B Hall
Journal:  J Pediatr       Date:  1999-08       Impact factor: 4.406

6.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.

Authors:  M Carrington; G W Nelson; M P Martin; T Kissner; D Vlahov; J J Goedert; R Kaslow; S Buchbinder; K Hoots; S J O'Brien
Journal:  Science       Date:  1999-03-12       Impact factor: 47.728

7.  Association between severe respiratory syncytial virus infection and IL13/IL4 haplotypes.

Authors:  Beena Puthothu; Marcus Krueger; Johannes Forster; Andrea Heinzmann
Journal:  J Infect Dis       Date:  2005-12-22       Impact factor: 5.226

8.  Identification of an H-2D(b)-restricted CD8+ cytotoxic T lymphocyte epitope in the matrix protein of respiratory syncytial virus.

Authors:  John A Rutigliano; Michael T Rock; Amanda K Johnson; James E Crowe; Barney S Graham
Journal:  Virology       Date:  2005-07-05       Impact factor: 3.616

9.  Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.

Authors:  Christoph Neumann-Haefelin; Susan McKiernan; Scott Ward; Sergei Viazov; Hans Christian Spangenberg; Thomas Killinger; Thomas F Baumert; Natalja Nazarova; Isabelle Sheridan; Oliver Pybus; Fritz von Weizsäcker; Michael Roggendorf; Dermot Kelleher; Paul Klenerman; Hubert E Blum; Robert Thimme
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

10.  Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection.

Authors:  R A Kaslow; M Carrington; R Apple; L Park; A Muñoz; A J Saah; J J Goedert; C Winkler; S J O'Brien; C Rinaldo; R Detels; W Blattner; J Phair; H Erlich; D L Mann
Journal:  Nat Med       Date:  1996-04       Impact factor: 53.440

View more
  11 in total

1.  Specific dietary oligosaccharides increase Th1 responses in a mouse respiratory syncytial virus infection model.

Authors:  Marcel A Schijf; Debby Kruijsen; Jacqueline Bastiaans; Frank E J Coenjaerts; Johan Garssen; Grada M van Bleek; Belinda van't Land
Journal:  J Virol       Date:  2012-08-15       Impact factor: 5.103

2.  Ginseng diminishes lung disease in mice immunized with formalin-inactivated respiratory syncytial virus after challenge by modulating host immune responses.

Authors:  Jong Seok Lee; Min Kyoung Cho; Hye Suk Hwang; Eun-Ju Ko; Yu-Na Lee; Young-Man Kwon; Min-Chul Kim; Ki-Hye Kim; Young-Tae Lee; Yu-Jin Jung; Sang-Moo Kang
Journal:  J Interferon Cytokine Res       Date:  2014-07-22       Impact factor: 2.607

Review 3.  Respiratory syncytial virus--a comprehensive review.

Authors:  Andrea T Borchers; Christopher Chang; M Eric Gershwin; Laurel J Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2013-12       Impact factor: 8.667

4.  Human CD8(+) T Cells Target Multiple Epitopes in Respiratory Syncytial Virus Polymerase.

Authors:  Daniel Burbulla; Patrick S Günther; Janet K Peper; Gerhard Jahn; Kevin M Dennehy
Journal:  Viral Immunol       Date:  2016-04-12       Impact factor: 2.257

Review 5.  Cellular GFP Toxicity and Immunogenicity: Potential Confounders in in Vivo Cell Tracking Experiments.

Authors:  Amir Mehdi Ansari; A Karim Ahmed; Aerielle E Matsangos; Frank Lay; Louis J Born; Guy Marti; John W Harmon; Zhaoli Sun
Journal:  Stem Cell Rev Rep       Date:  2016-10       Impact factor: 5.739

6.  Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection.

Authors:  Megan E Schmidt; Cory J Knudson; Stacey M Hartwig; Lecia L Pewe; David K Meyerholz; Ryan A Langlois; John T Harty; Steven M Varga
Journal:  PLoS Pathog       Date:  2018-01-02       Impact factor: 6.823

7.  Host genetics play a critical role in controlling CD8 T cell function and lethal immunopathology during chronic viral infection.

Authors:  Allison F Christiaansen; Megan E Schmidt; Stacey M Hartwig; Steven M Varga
Journal:  PLoS Pathog       Date:  2017-07-17       Impact factor: 6.823

8.  LAIR-1 Limits Neutrophilic Airway Inflammation.

Authors:  Kuldeep Kumawat; Ruben J Geerdink; Marije P Hennus; Mojtaba Abdul Roda; Ingrid van Ark; Thea Leusink-Muis; Gert Folkerts; Anita van Oort-Jansen; Alexandra Mazharian; Steve P Watson; Frank E Coenjaerts; Louis Bont; Linde Meyaard
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

Review 9.  Functional avidity: a measure to predict the efficacy of effector T cells?

Authors:  Selena Viganò; Daniel T Utzschneider; Matthieu Perreau; Giuseppe Pantaleo; Dietmar Zehn; Alexandre Harari
Journal:  Clin Dev Immunol       Date:  2012-11-20

10.  Whole Exome Sequencing reveals new candidate genes in host genomic susceptibility to Respiratory Syncytial Virus Disease.

Authors:  Antonio Salas; Jacobo Pardo-Seco; Miriam Cebey-López; Alberto Gómez-Carballa; Pablo Obando-Pacheco; Irene Rivero-Calle; María-José Currás-Tuala; Jorge Amigo; José Gómez-Rial; Federico Martinón-Torres
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.